OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The landscape of T cell antigens for cancer immunotherapy
Aviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Nature Cancer (2023) Vol. 4, Iss. 7, pp. 937-954
Closed Access | Times Cited: 60
Aviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Nature Cancer (2023) Vol. 4, Iss. 7, pp. 937-954
Closed Access | Times Cited: 60
Showing 1-25 of 60 citing articles:
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
Christopher A. Klebanoff, Smita S. Chandran, Brian M. Baker, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 996-1017
Open Access | Times Cited: 62
Christopher A. Klebanoff, Smita S. Chandran, Brian M. Baker, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 996-1017
Open Access | Times Cited: 62
Glioblastoma vaccines: past, present, and opportunities
Zujian Xiong, Itay Raphael, Michael R. Olin, et al.
EBioMedicine (2024) Vol. 100, pp. 104963-104963
Open Access | Times Cited: 28
Zujian Xiong, Itay Raphael, Michael R. Olin, et al.
EBioMedicine (2024) Vol. 100, pp. 104963-104963
Open Access | Times Cited: 28
Boosting Theranostic Performance of AIEgens Using Nanocatalyzer for Robust Cancer Immunotherapy
Yue Li, Zekun Du, Yuan Zhang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 23
Closed Access | Times Cited: 14
Yue Li, Zekun Du, Yuan Zhang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 23
Closed Access | Times Cited: 14
Phase and Defect Engineering of MoSe2 Nanosheets for Enhanced NIR-II Photothermal Immunotherapy
Zhusheng Huang, Jingrun Song, Shiqian Huang, et al.
Nano Letters (2024) Vol. 24, Iss. 25, pp. 7764-7773
Closed Access | Times Cited: 11
Zhusheng Huang, Jingrun Song, Shiqian Huang, et al.
Nano Letters (2024) Vol. 24, Iss. 25, pp. 7764-7773
Closed Access | Times Cited: 11
M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 8
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 8
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
Qiaohong Geng, Peifu Jiao
Molecules (2024) Vol. 29, Iss. 2, pp. 454-454
Open Access | Times Cited: 7
Qiaohong Geng, Peifu Jiao
Molecules (2024) Vol. 29, Iss. 2, pp. 454-454
Open Access | Times Cited: 7
Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
Xiaojing Qin, Wenjing Ning, Han Liu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2361-2377
Open Access | Times Cited: 7
Xiaojing Qin, Wenjing Ning, Han Liu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2361-2377
Open Access | Times Cited: 7
Parsing digital or analog TCR performance through piconewton forces
Aoi Akitsu, Eiji Kobayashi, Yinnian Feng, et al.
Science Advances (2024) Vol. 10, Iss. 33
Open Access | Times Cited: 7
Aoi Akitsu, Eiji Kobayashi, Yinnian Feng, et al.
Science Advances (2024) Vol. 10, Iss. 33
Open Access | Times Cited: 7
Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody
Shenxin Zeng, Mingfei Wu, Yuyuan Jin, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116206-116206
Closed Access | Times Cited: 6
Shenxin Zeng, Mingfei Wu, Yuyuan Jin, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116206-116206
Closed Access | Times Cited: 6
Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer
Laura Seclì, Guido Leoni, Valentino Ruzza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16591-16591
Open Access | Times Cited: 15
Laura Seclì, Guido Leoni, Valentino Ruzza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16591-16591
Open Access | Times Cited: 15
Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?
Alexander F. Wang, Brian Hsueh, Bryan D. Choi, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 5, pp. 628-643
Closed Access | Times Cited: 4
Alexander F. Wang, Brian Hsueh, Bryan D. Choi, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 5, pp. 628-643
Closed Access | Times Cited: 4
Recent developments in myeloid immune modulation in cancer therapy
Sepideh Parvanian, Xinying Ge, Christopher Garris
Trends in cancer (2025)
Closed Access
Sepideh Parvanian, Xinying Ge, Christopher Garris
Trends in cancer (2025)
Closed Access
Improving systemic delivery of oncolytic virus by cellular carriers
Ziyi Peng, Muhammad Kalim, Yong Lu
Cancer Biology and Medicine (2025) Vol. 21, Iss. 12, pp. 1104-1119
Open Access
Ziyi Peng, Muhammad Kalim, Yong Lu
Cancer Biology and Medicine (2025) Vol. 21, Iss. 12, pp. 1104-1119
Open Access
Dynamics of neoantigen-specific T-cells in post-transplant relapse: do leukemia neoantigens elicit immune responses in transplant recipients?
Biswas Neupane, Kedwin Ventura, Kayla Parr, et al.
Bone Marrow Transplantation (2025)
Closed Access
Biswas Neupane, Kedwin Ventura, Kayla Parr, et al.
Bone Marrow Transplantation (2025)
Closed Access
Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapy
Yishen Tian, Jingxuan Li, Na Yang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101545-101545
Open Access
Yishen Tian, Jingxuan Li, Na Yang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101545-101545
Open Access
Knowledge structures and research hotspots of immunotherapy for brain metastasis, glioma, meningioma, and pituitary adenoma: A bibliometric and visualization review
Donghu Yu, Jin Wang, Lei Hu, et al.
Chinese Chemical Letters (2025), pp. 110995-110995
Closed Access
Donghu Yu, Jin Wang, Lei Hu, et al.
Chinese Chemical Letters (2025), pp. 110995-110995
Closed Access
Integrated immunological analysis of single-cell and bulky tissue transcriptomes reveals the role of prognostic value of T cell-related genes in cervical cancer
Yao Fu, Xiubing Zhang, Lili Yu, et al.
Computer Methods in Biomechanics & Biomedical Engineering (2025), pp. 1-21
Closed Access
Yao Fu, Xiubing Zhang, Lili Yu, et al.
Computer Methods in Biomechanics & Biomedical Engineering (2025), pp. 1-21
Closed Access
Mutated DNMT3A creates a public HLADQ- binding neoantigen on acute myeloid leukemia
Dyantha I. van der Lee, Eva M. Argiro, Sebastiaan N. J. Laan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Dyantha I. van der Lee, Eva M. Argiro, Sebastiaan N. J. Laan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
CAR-γδ T Cells Targeting Claudin18.2 Show Superior Cytotoxicity Against Solid Tumor Compared to Traditional CAR-αβ T Cells
Yueqi Zhao, Yinghui Li, Shuaiqi Wang, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 998-998
Open Access
Yueqi Zhao, Yinghui Li, Shuaiqi Wang, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 998-998
Open Access
Rejuvenation of Tumor‐Specific T Cells via Ultrahigh DAR Antibody‐Polymeric Imidazoquinoline Complexes: Coordinated Targeting of PDL1 and Efficient TLR7/8 Activation in Intratumoral Dendritic Cells
Hongyu Chu, Yuezhan Shan, Zongyu Liu, et al.
Advanced Materials (2025)
Closed Access
Hongyu Chu, Yuezhan Shan, Zongyu Liu, et al.
Advanced Materials (2025)
Closed Access
A carrier-free DNA nanoplatform for efficient three-in-one tumor therapy in vivo
Hong Wang, Xuehe Lu, Jing Fan, et al.
Nano Today (2025) Vol. 62, pp. 102734-102734
Closed Access
Hong Wang, Xuehe Lu, Jing Fan, et al.
Nano Today (2025) Vol. 62, pp. 102734-102734
Closed Access
Advances in Vaccines for Melanoma
Can Cui, Patrick A. Ott, Catherine J. Wu
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 5, pp. 1045-1060
Closed Access | Times Cited: 4
Can Cui, Patrick A. Ott, Catherine J. Wu
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 5, pp. 1045-1060
Closed Access | Times Cited: 4
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer
Maria Tredicine, Matteo Mucci, Antonio Recchiuti, et al.
FEBS Letters (2025)
Open Access
Maria Tredicine, Matteo Mucci, Antonio Recchiuti, et al.
FEBS Letters (2025)
Open Access
Cancer vaccines: from an immunology perspective
Shania Makker, Charlotte Galley, Clare L. Bennett
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 10
Shania Makker, Charlotte Galley, Clare L. Bennett
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 10
The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapy
Raquel S. Laureano, Isaure Vanmeerbeek, Jenny Sprooten, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 71-93
Closed Access | Times Cited: 9
Raquel S. Laureano, Isaure Vanmeerbeek, Jenny Sprooten, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 71-93
Closed Access | Times Cited: 9
